Healthpeak Properties, Inc. (DOC)
NYSE: DOC · Real-Time Price · USD
18.75
+0.17 (0.89%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Healthpeak Properties Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Healthpeak Properties stock have an average target of 24, with a low estimate of 21 and a high estimate of 28. The average target predicts an increase of 28.03% from the current stock price of 18.75.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Healthpeak Properties stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 2 | 2 | 1 |
| Buy | 5 | 6 | 6 | 6 | 6 | 6 |
| Hold | 5 | 5 | 5 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 11 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $24 | Buy | Reiterates | $24 | +28.03% | Apr 11, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $24 → $23 | Buy | Maintains | $24 → $23 | +22.70% | Feb 28, 2025 |
| Wedbush | Wedbush | Buy Maintains $24 → $27 | Buy | Maintains | $24 → $27 | +44.04% | Feb 14, 2025 |
| Baird | Baird | Buy Maintains $25 → $24 | Buy | Maintains | $25 → $24 | +28.03% | Feb 11, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $23 → $22 | Hold | Maintains | $23 → $22 | +17.36% | Dec 10, 2024 |
Financial Forecast
Revenue This Year
2.81B
from 2.70B
Increased by 3.98%
Revenue Next Year
2.92B
from 2.81B
Increased by 4.10%
EPS This Year
0.22
from 0.36
Decreased by -37.72%
EPS Next Year
0.28
from 0.22
Increased by 26.63%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.0B | 3.2B | 3.3B |
| Avg | 2.8B | 2.9B | 3.0B |
| Low | 2.6B | 2.7B | 2.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 12.0% | 14.2% | 11.8% |
| Avg | 4.0% | 4.1% | 3.9% |
| Low | -4.1% | -5.4% | -1.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.28 | 0.36 | 0.40 |
| Avg | 0.22 | 0.28 | 0.29 |
| Low | 0.17 | 0.20 | 0.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -20.9% | 59.9% | 41.1% |
| Avg | -37.7% | 26.6% | 3.6% |
| Low | -53.5% | -12.2% | -30.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.